[Automatic translation follows] Tailor-made support for your innovation projects The Technology Transfer Acceleration Company (SATT) – Ouest Valorisation SAS was created on July 20, 2012 as part of the Investments for the Future. Its mission is to accelerate the transfer of research results from public research laboratories to partners: VSEs/SMEs, large groups, local authorities, associations. It thus supports researchers working in 28 higher education institutions (universities, engineering schools and university hospitals) as well as 3 research organizations located in one of the university centers of Brittany or Pays de la Loire (Angers, Brest, Le Mans, Lorient-Vannes, Nantes, Rennes). With 70 …

Tags: SATT Network Sectors: Research Startup accelerator & VC

Detecting promising #deeptech and fostering the creation of #startups with Grenoble Alpes IP inside . Linksium, Société d’Accélération du Transfert de Technologies (SATT) de Grenoble Alpes détecte projets prometteurs issus de la recherche publique, finance et accompagne la création de startups #deeptech. Detecting promising technologies, funding and fostering the creation of deeptech #startups in the French Alps area. Technology transfert, Startups building, deeptech, venture capital, Research & development , and R&D

Tags: SATT Network

Building a future we can all trust. Thales (Euronext Paris: HO) is a global leader in advanced technologies specialized in three business domains: Defence & Security, Aeronautics & Space, and Cybersecurity & Digital identity. It develops products and solutions that help make the world safer, greener and more inclusive. The Group invests close to €4 billion a year in Research & Development, particularly in key innovation areas such as AI, cybersecurity, quantum technologies, cloud technologies and 6G. Thales has close to 81,000 employees in 68 countries. In 2023, the Group generated sales of €18.4 billion. Aerospace, Defence, Security, Space, Cybersecurity, …

Tags: CAC40 Sectors: Defence and Aerospace

Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy

Sectors: Biotechnology